Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Genome-based Drug Discovery

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1788234

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1788234

Optical Genome Mapping

PUBLISHED:
PAGES: 208 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Optical Genome Mapping Market to Reach US$615.2 Million by 2030

The global market for Optical Genome Mapping estimated at US$139.6 Million in the year 2024, is expected to reach US$615.2 Million by 2030, growing at a CAGR of 28.0% over the analysis period 2024-2030. Optical Genome Mapping Services, one of the segments analyzed in the report, is expected to record a 28.9% CAGR and reach US$332.6 Million by the end of the analysis period. Growth in the Optical Genome Mapping Consumables & Reagents segment is estimated at 29.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$36.7 Million While China is Forecast to Grow at 26.5% CAGR

The Optical Genome Mapping market in the U.S. is estimated at US$36.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$92.9 Million by the year 2030 trailing a CAGR of 26.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 25.7% and 24.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 19.3% CAGR.

Global Optical Genome Mapping Market - Key Trends & Drivers Summarized

Why Is Optical Genome Mapping Disrupting Conventional Genomic Analysis?

Optical Genome Mapping (OGM) is emerging as a transformative force in genomic research and diagnostics, offering unprecedented resolution and accuracy in identifying structural variations (SVs) that are often missed by traditional sequencing technologies. While next-generation sequencing (NGS) has revolutionized genomics, it remains limited in detecting large-scale genomic rearrangements such as insertions, deletions, inversions, and translocations-areas where OGM excels. By utilizing ultra-long DNA molecules and imaging them in nanochannel arrays, OGM allows for real-time visualization of structural features across the entire genome without amplification or fragmentation. This capability is proving especially valuable in complex genetic disorders, hematological malignancies, solid tumors, and rare diseases, where understanding structural anomalies is critical for diagnosis and treatment planning. The growing need for comprehensive genomic profiling in personalized medicine, coupled with the demand for cost-effective and scalable solutions, is pushing academic institutions, clinical laboratories, and biotech companies to adopt OGM as a complementary or even primary tool. Its ability to integrate seamlessly with existing bioinformatics pipelines while offering insights that sequencing alone cannot provide is reshaping research workflows and expanding the utility of genomic data in translational and clinical applications.

How Are Technological Advances Enhancing the Performance and Accessibility of OGM?

The Optical Genome Mapping landscape is being rapidly reshaped by significant technological advancements that are making the platform more robust, user-friendly, and accessible across a broader range of applications. Improvements in nanochannel chip design and automated sample preparation are reducing hands-on time and increasing throughput, making OGM more practical for both high-volume clinical labs and academic research centers. The integration of AI and machine learning algorithms is enhancing the accuracy of structural variant calling and interpretation, minimizing human error and allowing for more reliable diagnostics. At the same time, cloud-based platforms for data analysis are simplifying collaboration between researchers and clinicians, enabling secure, real-time access to genomic insights. Miniaturization and portability efforts are also underway, with the goal of making OGM platforms suitable for decentralized and point-of-care environments. The ability to analyze ultra-high molecular weight DNA from various sample types-blood, bone marrow, solid tissue-without complex processing is expanding the method’s utility. Moreover, advancements in fluorescent labeling chemistries and optical detection are improving signal clarity, allowing for more precise mapping of structural elements across large genomes. As these innovations continue, they are not only lowering the barriers to adoption but also setting new standards in speed, scalability, and sensitivity for genomic analysis.

What End-Use Sectors Are Driving Demand and Expanding Application Frontiers?

The demand for Optical Genome Mapping is accelerating across a diverse set of end-use sectors, each leveraging the technology for distinct yet overlapping purposes. In clinical diagnostics, hematology and oncology are the most active domains, with OGM being used to uncover structural variants associated with leukemias, lymphomas, and solid tumors-many of which are undetectable through conventional karyotyping or chromosomal microarrays. In reproductive genetics, OGM is gaining traction for pre- and post-natal diagnostics of chromosomal abnormalities such as aneuploidies and copy number variations. Academic research institutions and genome centers are also adopting OGM for population studies, evolutionary biology, and functional genomics, due to its ability to uncover complex genomic architectures and gene regulatory networks. In the biopharmaceutical sector, OGM is being integrated into drug discovery pipelines, especially in biomarker identification and characterization of genetic instability in engineered cell lines. Agricultural genomics is another emerging area, where OGM is used to map plant genomes for crop improvement and trait selection. These broad and expanding use cases are driving demand for versatile OGM platforms that can operate across different sample types and data analysis environments. Furthermore, collaborations between technology providers and healthcare institutions are catalyzing validation studies and clinical adoption, pushing the market toward widespread acceptance.

What Forces Are Powering the Growth of the Optical Genome Mapping Market?

The growth in the Optical Genome Mapping market is driven by several factors related to technological evolution, end-user demands, and shifts in genomic research and diagnostic priorities. The growing need for high-resolution structural variant detection, particularly in oncology and rare disease diagnostics, is pushing laboratories to integrate OGM into their workflows. The limitations of short-read sequencing in identifying large-scale genomic alterations are creating a complementary demand for OGM, especially in cases where comprehensive genome structural profiling is essential. Advancements in automated instrumentation, improved nanochannel array designs, and scalable data analysis platforms are making OGM more user-friendly and operationally efficient. Increasing funding for genomic medicine and precision oncology, especially from government and private healthcare initiatives, is expanding the customer base among hospitals and specialty labs. The integration of OGM with multi-omics approaches and bioinformatics ecosystems is creating opportunities for end-to-end, systems-level insights in both research and clinical domains. Rising awareness among clinicians and geneticists about the unique value of OGM in solving previously undiagnosable cases is accelerating adoption. In emerging markets, the push for improved rare disease detection and cost-effective cancer diagnostics is encouraging investment in non-sequencing-based genomic tools. These cumulative drivers are establishing Optical Genome Mapping as a critical enabler in the next era of precision diagnostics and genomic discovery.

SCOPE OF STUDY:

The report analyzes the Optical Genome Mapping market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software, Optical Genome Mapping Instruments); Technique (Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique, Other Techniques); Application (Research Application, Diagnostics Application); End-Use (Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use, Biotechnology & Pharmaceutical Companies End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Agilent Technologies Inc.
  • Bionano Genomics
  • Bio-Rad Laboratories Inc.
  • Cerba Research
  • Genohub Inc.
  • Hamilton Company
  • Hofkens Lab
  • Illumina Inc.
  • INRAE (French Plant Genomic Resources Center)
  • MedGenome
  • Nabsys
  • NanoString Technologies
  • Nucleome Informatics
  • OpGen
  • Oxford Nanopore Technologies
  • PacBio (Pacific Biosciences)
  • PerkinElmer Genomics
  • Praxis Genomics, LLC
  • QIAGEN N.V.
  • Source BioScience

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

Show more
Product Code: MCP32436

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Optical Genome Mapping - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Limitations of Traditional Sequencing Technologies Throw the Spotlight on Structural Variant Detection Through Optical Genome Mapping (OGM)
    • Surge in Rare Disease and Oncology Research Spurs Growth in High-Resolution, Non-Sequencing-Based Genomic Tools
    • Clinical Demand for Comprehensive Genomic Profiling Expands Addressable Market Opportunity for OGM Platforms
    • Integration with Multi-Omics and Bioinformatics Pipelines Strengthens the Business Case for Complementary Use of OGM
    • Advancements in AI-Powered Structural Variant Interpretation Drive Adoption in Clinical and Translational Research
    • Increased Focus on Personalized Medicine Accelerates Demand for Genome-Wide, High-Fidelity Mapping Technologies
    • Automation of Sample Prep and Nanochannel Imaging Enhances Throughput and Enables Scalability in High-Volume Labs
    • Rising Application in Prenatal, Pediatric, and Reproductive Health Creates New Use Cases for OGM in Cytogenetics
    • Adoption in Cell and Gene Therapy Research Fuels Demand for Structural Integrity Mapping in Engineered Cell Lines
    • Global Expansion of Genomic Medicine Programs Sustains Growth in Emerging Markets With Unmet Diagnostic Needs
    • Technological Innovation in DNA Labeling and Imaging Systems Drives Performance Enhancements in Mapping Accuracy
    • Growing Recognition of OGM as a Complement to Short- and Long-Read Sequencing Encourages Platform Convergence
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Optical Genome Mapping Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Optical Genome Mapping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Optical Genome Mapping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Optical Genome Mapping Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Optical Genome Mapping Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Optical Genome Mapping Consumables & Reagents by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Optical Genome Mapping Consumables & Reagents by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Optical Genome Mapping Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Optical Genome Mapping Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Optical Genome Mapping Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Optical Genome Mapping Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Diagnostics Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Diagnostics Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Research Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Research Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Academic Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Academic Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Hospitals & Clinical Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Hospitals & Clinical Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Biotechnology & Pharmaceutical Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Biotechnology & Pharmaceutical Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Structural Variant Detection Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Structural Variant Detection Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Genome Assembly Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Genome Assembly Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Microbial Strain Typing Technique by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Microbial Strain Typing Technique by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Optical Genome Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • JAPAN
    • Optical Genome Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • CHINA
    • Optical Genome Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 54: China Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 55: China 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 56: China Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • EUROPE
    • Optical Genome Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe 6-Year Perspective for Optical Genome Mapping by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • FRANCE
    • Optical Genome Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 72: France Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 73: France 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 74: France Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • GERMANY
    • Optical Genome Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 80: Germany Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Germany 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • ITALY
    • TABLE 88: Italy Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Italy 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • UNITED KINGDOM
    • Optical Genome Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 96: UK Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 97: UK 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 98: UK Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Optical Genome Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Asia-Pacific 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 120: Rest of World Recent Past, Current & Future Analysis for Optical Genome Mapping by Product - Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Rest of World 6-Year Perspective for Optical Genome Mapping by Product - Percentage Breakdown of Value Sales for Optical Genome Mapping Services, Optical Genome Mapping Consumables & Reagents, Optical Genome Mapping Software and Optical Genome Mapping Instruments for the Years 2025 & 2030
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Optical Genome Mapping by Application - Diagnostics Application and Research Application - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Optical Genome Mapping by Application - Percentage Breakdown of Value Sales for Diagnostics Application and Research Application for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Optical Genome Mapping by End-Use - Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Optical Genome Mapping by End-Use - Percentage Breakdown of Value Sales for Academic Research Institutes End-Use, Hospitals & Clinical Laboratories End-Use and Biotechnology & Pharmaceutical Companies End-Use for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Optical Genome Mapping by Technique - Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Optical Genome Mapping by Technique - Percentage Breakdown of Value Sales for Structural Variant Detection Technique, Genome Assembly Technique, Microbial Strain Typing Technique and Other Techniques for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!